Scientific Abstracts
Results: 15 patients were included: 11 women and 4 men, with a mean age of 42.2 years (SD+/-16) The genetic study was performed in 12 patients: 75% were positive for HLA DQ2 and 25% for HLA DQ8. The determination of antibodies was positive in 12 patients (73%) and negative in 3 (27%). These 3 were positive for the genetic study (2 HLA DQ2 and 1 HLA DQ8). The study of BD showed: type I in 4 patients; Type IIIa in 2 patients; Type IIIb in 6 patients; Type IIIC in 3 patients. BMD showed normal values in 33%, osteopenia in 47% and osteoporosis (OP) in 20% of patients. Thus, 67% had an alteration in BMD at the time of diagnosis. 100% had a Vit D deficit, with a mean value of 14.3 ng/mL (range 4.15-26.8). 75% of them had values below 20 ng/mL (40% less than 10 ng/mL). 40% had secondary hyperparathyroidism (SHP), 83% of which had an alteration in BMD (67% osteopenia and 16% OP). Background: Menopaused and osteoporotic women have a higher risk of fractures when falling. Fall prevention is important when taking care of those women. Objectives: After identifying fall risk factors, defining the % of fractured fallers and the part of osteoporotic women in this population, we want to evaluate the relevance of balance tests and to favor prevention measures for those patients. Methods: 110 patients, 60 years and older (including 24 controls), having falled within a year, have seen 28 private practice rheumatologists in the larger Paris area and were subject of our multicentre retrospective study. Results: Fallers mean age was 75 years. 37% of the fallers within a year fractured after falling. Among them, 95% were post-menopausal fractures versus 64% when including the control group. Post-fall or post menopausal fracture sites are identical. In order: spine 26%, wrist 18%, ribs 6%. The circumstances of the falls are: 1) lack of attention 2) slipping 3) stumbling. 61% of the fallers have at least one physical activity, among them 71% a weight-bearing physical activity. The most common physical activity was walking (46%). Among the fractured, 32% had physical activity, 42% hadn't. 72% of the fallers had at least one fall risk factor: 94% had intrinsic risk factors, 28% extrinsic, and an average of 2 risk factors within the older than 80 years. Intrinsic factors: 1) osteo-articular 2) eye-vision 3) postural 4) drugs, out of 13 items. Extrinsic: 1) obstacles 2) footwear out of 7 items. 45% of the fallers within a year had at least one osteoporosis risk factor: 1) low body mass index 2) cortico-steroids 3) early menopausis 4) smoking, out of 9 items. 70% of our patients had vitamin D level>30 ng/l (as recommanded) 69% of the patients had recent bone density measures: bone density was lower only at femoral neck of fractured fallers versus non fractured fallers. The unipodal balance test (positive when standing less than 5 seconds) was relevant in 42% of the patients with or without fractures. Get up and go test was not relevant in our study population. 94% of the rheumatologists participating in the study recommend at least 2 fall prevention measures: 1) correct vitamin D levels 2) physical activity 3) reeducation 4) eye vision correction, out of 12 items. Conclusions: A significant part of menopaused women with anteriority of falls and fractures will refracture after falling again. 
Background:
99 Tc-MDP has been used in Chinese RA patients for over 15 years and many more studies have focused on this agent in RA. However, the previous studies limited in its effect on the effects of anti-inflammation. As a special form of bisphosphonate, the anti-osteoporotic effect of 99 Tc-MDP is unclear. Objectives: To systematically investigate the effect of technetium-99 conjugated with methylene diphosphonate ( 99 Tc-MDP), an anti-inflammatory drug effective in treating rheumatoid arthritis (RA), on cortical and cancellous bones in glucocorticoid-induced osteoporotic (GIO) rats, as well as comparing the effect of 99 Tc-MDP with that of methylene diphosphonate (MDP). Methods: Forty-eight Sprague-Dawley rats were randomly divided into six groups: blank, negative control, high dose, medium dose, low dose, and positive control groups. After dexamethasone was given to all groups except the blank group to induce osteoporosis, the rats in different groups were treated with saline, MDP, or different doses of Results: Micro-CT analyses showed that: (1) 99 Tc-MDP reversed glucocorticoid induced bone microarchitecture destruction by increasing vBMD, BV/TV, Tb.Th, Tb.N and decreasing BS/BV, Tb.Sp and TBPf; (2) effect of 99 Tc-MDP increased as its dosage increased; and (3) 99 Tc-MDP could improve cortical bone thickness while MDP failed to do so. Micro-CT spatial structure analysis and histology also yielded consistent results, indicating 99 Tc-MDP increased trabecular number and connectivity morphologically. Finally, biomechanics revealed 99 Tc-MDP can enhance the extrinsic stiffness of bone by changing bone geometry.
Conclusions:
99 Tc-MDP has anti-osteoporotic effect by improving both cancellous and cortical bone, as well as increasing extrinsic bone stiffness. The dual effect of 99 Tc-MDP, anti-inflammatory and anti-osteoporotic, may suggest a potential clinical application for patients with both GIO and RA. 
